Neurobiology of glaucomatous optic neuropathy: Diverse cellular events in neurodegeneration and neuroprotection

Molecular Neurobiology

Volumn 26, Issue 1, 2002, Pages 45-55

  Wax, M B ^a,b   Tezel, G ^c  

^a PFIZER INC   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Apoptosis; Glaucoma; Neurodegeneration; Neuroprotection; Retinal ganglion cells

Indexed keywords

ANTIGEN; HEAT SHOCK PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; AUTOIMMUNE DISEASE; BRAIN NERVE CELL; CELL ACTIVATION; CELL ACTIVITY; CELL PROTECTION; CELL SURVIVAL; CELLULAR IMMUNITY; GLAUCOMA; IMMUNE SYSTEM; NERVE DEGENERATION; NERVE FIBER; NEUROBIOLOGY; NEUROPROTECTION; NONHUMAN; OPTIC NERVE DISEASE; REGULATORY MECHANISM; RETINA GANGLION CELL; REVIEW;

EID: 0036700129     PISSN: 08937648     EISSN: None     Source Type: Journal    
DOI: 10.1385/mn:26:1:045     Document Type: Review

References (102)

1. Quigley H. A. (1993) Open-angle glaucoma. N. Eng. J. Med. 328, 1097-1106.
2. Tielsch J. M., Sommer A., Witt K., Katz J., and Royall R. M. (1990) Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch. Ophthalmol. 108, 286-290.
3. Tielsch J. M., Sommer A., Katz J., Royall R. M., Quigley H. A., and Javitt J. (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266, 369-374.
4. Quigley H. A. (1996) Number of people with glaucoma worldwide. Br. J. Ophthalmol. 80, 389-393.
5. Tezel G., Siegmund K. D., Trinkaus K., Wax M. B., Kass M. A., and Kolker A. E. (2001) Clinical factors associated with progression of glaucomatous optic disc damage in treated patients. Arch. Ophthalmol. 19, 813-818.
6. Quigley H. A., Nickells R. W., Kerrigan L. A., Pease M. E., Thibault D. J., and Zack D. J. (1995) Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest. Ophthalmol. Vis Sci. 36, 774-786.
7. Garcia-Valenzuela E., Shareef S., Walsh J., and Sharma S. C. (1995) Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye. Res. 61, 33-44.
8. Li Y., Schlamp C. L., and Nickells R. W. (1999) Experimental induction of retinal ganglion cell death in adult mice. Invest. Ophthalmol. Vis. Sci. 40, 1004-1008.
9. Kerrigan L. A., Zack D. J., Quigley H. A., Smith S. D., and Pease M. E. (1997) TUNEL-positive ganglion cells in human primary open-angle glaucoma. Arch. Ophthalmol. 115, 1031-1035.
10. Wax M. B., Tezel G., and Edward P. D. (1998) Clinical and ocular histopathological findings in a patient with normal-pressure glaucoma. Arch. Ophthalmol. 116, 993-1001.
11. Hayreh S. S. (1985) Inter-individual variation in blood supply of the optic nerve head. Its importance in various ischemic disorders of the optic nerve head, and glaucoma, low-tension glaucoma and allied disorders. Doce. Ophthalmol. 59, 217-246.
12. Van Buskirk E. M. and Cioffi G. A. (1992) Glaucomatous optic neuropathy. Am. J. Ophthalmol. 113, 447-452.
13. Flammer J. (1994) The vascular concept of glaucoma. Surv. Ophthalmol. 38 Suppl, S3-6.
14. Chung H. S., Harris A., Evans D. W., Kagemann L., Garzozi H. J., and Martin B. (1999) Vascular aspects in the pathophysiology of glaucomatous optic neuropathy. Surv. Ophthalmol. 43 Suppl 1, S43-50.
15. Anderson D. R. Jand Hendrickson A. (1974) Effect of intraocular pressure on rapid axoplasmic transport in monkey optic nerve. Invest. Ophthalmol. 13, 771-783.
16. Minckler D. S., Tso M. O., and Zimmerman L. E. (1976) A light microscopic, autoradiographic study of axoplasmic transport in the optic nerve head during ocular hypotony, increased intraocular pressure, and papilledema. Am. J. Ophthalmol. 82, 741-757.
17. Quigley H. A. and Addicks E. M. (1980) Chronic experimental glaucoma in primates. II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest. Ophthalmol. Vis. Sci. 19, 137-152.
18. Pease M. E., McKinnon S. J., Quigley H. A., Kerrigan-Baumrind L. A., and Zack D. J. (2000) Obstructed axonal transport of BDNF and its receptor TrkB in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 41, 764-774.
19. Levin L. A. (1999) Direct and indirect approaches to neuroprotective therapy of glaucomatous optic neuropathy. Surv. Ophthalmol. 43 (Suppl 1), S98-101.
20. Neufeld A. H., Sawada A., and Becker B. (1999) Inhibition of nitric-oxide synthase 2 by aminoguanidine provides neuroprotection of retinal ganglion cells in a rat model of chronic glaucoma. Proc. Natl. Acad. Sci. USA 96, 9944-9948.
21. Jonas J. B., Fernandez M. C., and Sturmer J. (1993) Pattern of glaucomatous neuroretinal rim loss. Ophthalmology 100, 63-68.
22. Araie M. (1995) Pattern of visual field defects in normal-tension and high-tension glaucoma. Curr. Opin. Ophthalmol. 6, 36-45.
23. Tezel G., Dorr D., Kolker A. E., Wax M. B., and Kass M. A. (2000) Concordance of parapapillary chorioretinal atrophy inocular hypertension with visual field defects that accompany glaucoma development. Ophthalmology 107, 1194-1199.
24. Glovinsky Y., Quigley H. A., and Dunkelberger G. R. (1991) Retinal ganglion cell loss is. size dependent in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 32, 484-491.
25. Glovinsky Y., Quigley H. A., and Pease M. E. (1993) Foveal ganglion cell loss is size dependent in experimental glaucoma. Invest. Ophthalmol. Vis. Sci. 34, 395-400.
26. Dreyer E. B., Zurakowski D., Schumer R. A., Podos S. M., and Lipton S. A. (1996) Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch. Ophthalmol. 114, 299-305.
27. Wax M. B., Barrett D. A., and Pestronk A. (1994) Increased incidence of paraproteinemia and autoantibodies in patients with normalpressure glaucoma. Am. J. Ophthalmol. 117, 561-568.
28. Tezel G. and Wax M. B. (2000) The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J. Neurosci. 20, 3552-3562.
29. Tezel G. and Wax M. B. (1999) Inhibition of caspase activity in retinal cell apoptosis induced by various stimuli in vitro. Invest. Ophthalmol. Vis. Sci. 40, 2660-2667.
30. Tezel G. and Wax M. B. (2000) Increased production of tumor necrosis factor-alpha by glial cells exposed to simulated ischemia or elevated hydrostatic pressure induces apoptosis in cocultured retinal ganglion cells. J. Neurosci. 20, 8693-8700.
31. Finn J. T., Weil M., Archer F., Siman R., Srinivasan A., and Raff M. C. (2000) Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20, 1333-1341.
32. Schwartz M., Yoles E., and Levin L. A. (1999) 'Axogenic' and 'somagenic' neurodegenerative diseases: definitions and therapeutic implications. Mol. Med. Today. 5, 470-473.
33. Yoles E. and Schwartz M. (1998) Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies. Exp. Neurol. 153, 1-7.
34. Levkovitch-Verbin H., Quigley H. A., Kerrigan-Baumrind L. A., D'Anna S. A., Kerrigan D., and Pease M. E. (2001) Optic nerve transection in monkeys may result in secondary degeneration of retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 42, 975-982.
35. Tanihara H., Hangai M., Sawaguchi S., Abe H., Kageyama M., Nakazawa F., Shirasawa E., and Honda Y. (1997) Up-regulation of glial fibrillary acidic protein in the retina of primate eyes with experimental glaucoma. Arch Ophthalmol. 115, 752-756.
36. Wang X., Tay S. S., and Ng Y. K. (2000) An immunohistochemical study of neuronal and glial cell reactions in retinae of rats with experimental glaucoma. Exp. Brain Res. 132, 476-484.
37. Wang L., Cioffi G. A., Cull G., Dong J., and Fortune B. (2002) Immunohistologic evidence for retinal glial cell changes in human glaucoma. Invest. Ophthalmol. Vis. Sci. 43, 1088-1094.
38. Hernandez M. R. and Pena J. D. (1997) The optic nerve head in glaucomatous optic neuropathy. Arch. Ophthalmol. 115, 389-395.
39. Ridet J. L., Malhotra S. K., Privat A., and Gage F. H. (1997) Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 20, 570-577.
40. Perez S. E. and Steller H. (1996) Migration of glial cells into retinal axon target field in Drosophila melanogaster. J. Neurobiol. 30, 359-373.
41. Anderson C. M. and Swanson R. A. (2000) Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 1-14.
42. Vorwerk C. K., Naskar R., Schuettauf P., Quinto K., Zurakowski D., Gochenauer G., et al. (2000) Depression of retinal glutamate transporter function leads to elevated intravitreal glutamate levels and ganglion cell death. Invest. Ophthalmol Vis. Sci. 41, 3615-3621.
43. Yan X., Tezel G., Wax M. B., and Edward D. P. (2000) Matrix metalloproteinases and tumor necrosis factor alpha in glaucomatous optic nerve head. Arch. Ophthalmol. 118, 666-673.
44. Agapova O. A., Ricard C. S., Salvador-Silva M., and Hernandez M. R. (2001) Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 33, 205-216.
45. Hernandez M. R. (2000) The optic nerve headin glaucoma: role of astrocytes in tissue remodeling. Prog. Retin Eye Res. 19, 297-321.
46. Tezel G., Hernandez M. R., and Wax M. B. (2001) In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head. Glia 34, 178-189.
47. Neufeld A. H., Hernandez M. R., and Gonzalez M. (1997) Nitric oxide synthase in the human glaucomatous optic nerve head. Arch. Ophthalmol. 115, 497-503.
48. Yuan L. and Neufeld A. H. (2000) Tumor necrosis factor-alpha: a potentially neurodestructive cytokine produced by glia in the human glaucomatous optic nerve head. Glia 32, 42-50.
49. Yuan J., Shaham S., Ledoux S., Ellis H. M., and Horvitz H. R. (1993) The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75, 641-652.
50. Lazebnik Y. A., Kaufmann S. H., Desnoyers S., Poirier G. G., and Earnshaw W. C. (1994) Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371, 346-347.
51. Hsu H., Xiong J., and Goeddel D. V. (1995) The TNF receptor 1-associated protein TRADD signals cell death and NF- kappa B activation. Cell 81, 495-504.
52. Fernandes-Alnemri T., Litwack G., and Alnemri E. S. (1994) CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta- converting enzyme. J. Biol. Chem. 269, 30761-30764.
53. Liu X., Kim C. N., Yang J., Jemmerson R., and Wang X. (1996) Induction of apoptotic program in cell-free extracts: requirement fordATP and cytochrome c. Cell 86, 147-157.
54. Zou H., Henzel W. J., Liu X., Lutschg A., and Wang X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.
55. Vaux D. L., Cory S., and Adams J. M. (1988) Bcl-2 gene promotes haemopoietic cell survival and cooperates with c- myc to immortalize pre-B cells. Nature 335, 440-442.
56. Hockenbery D. M., Oltvai Z. N., Yin X. M., Milliman C. L., and Korsmeyer S. J. (1993) Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75, 241-251.
57. Yang J., Liu X., Bhalla K., Kim C. N., Ibrado A. M., Cai J., Peng T. I., Jones D. P., and Wang X. (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275, 1129-1132.
58. Kluck R. M., Bossy-Wetzel E., Green D. R., and Newmeyer D. D. (1997) The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis. Science 275, 1132-1136.
59. Li P., Nijhawan D., Budihardjo I., Srinivasula S. M., Ahmad M., Alnemri E. S., and Wang X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
60. Tewari M., Quan L. T., O'Rourke K., Desnoyers S., Zeng Z., Beidler D. R., et al. (1995) Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81, 801-809.
61. Bonfanti L., Strettoi E., Chierzi S., Cenni M. C., Liu X. H., Martinou J. C., et al. (1996) Protection of retinal ganglion cells from natural and axotomy-induced cell death in neonatal transgenic micg overexpressing bcl-2. J. Neurosci. 16, 4186-4194.
62. Levin L. A., Schlamp C. L., Spieldoch R. L., Geszvain K. M., and Nickells R. W. (1997) Identification of the bcl-2 family of genes in the rat retina. Invest. Ophthalmol. Vis. Sci. 38, 2545-2553.
63. Tezel G. M., Seigel G. M., and Wax M. B. (1999) Density-dependent resistance to apoptosis in retinal cells. Curr. Eye Res. 19, 377-388.
64. Arrowsmith C. H. (1999) Structure and function in the p53 family. Cell Death Differ. 6, 1169-1173.
65. Wang X. W. (1999) Role of p53 and apoptosis in carcinogenesis. Anticancer Res. 19, 4759-4771.
66. Nickells R. W. (1999) Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv. Ophthalmol. 43 Suppl 1, S151-161.
67. Mittag T. W., Danias J., Pohorenec G., Yuan H. M., Burakgazi E., Chalmers-Redman R., et al. (2000) Retinal damage after 3 to 4 months of elevated intraocular pressure in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 41, 3451-3459.
68. Tatton W. G., Chalmers-Redman R. M., Sud A., Podos S. M., and Mittag T. W. (2001) Maintaining mitochondrial membrane impermeability, an opportunity for new therapy in glaucoma? Surv. Ophthalmol. 45 Suppl 3, S277-283.
69. McKinnon S. J., Lehman D. M., Kerrigan-Baumrind L. A., Merges C. A., Pease M. E., Kerrigan D. F., et al. (2002) Caspase activation and amyloid precursor protein cleavage in rat ocular hypertension. Invest. Ophthalmol. Vis. Sci. 43, 1077-1087.
70. Tezel G., Li L. Y., Patil R. V., and Wax M. B. (2001) Tumor necrosis factor-alpha and its receptor-1 in the retina of normal and glaucomatous eyes. Invest. Ophthalmol. Vis. Sci. 1787-1794.
71. Rezaie T., Child A., Hitchings R., Brice G., Miller L., Coca-Prados M., et al. (2002) Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science 295, 1077-1079.
72. Mattson M. P., Culmsee C., Yu Z., and Camandola S. (2000) Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74, 443-456.
73. Magnusson C. and Vaux D. L. (1999) Signalling by CD95 and TNF receptors: not only life and death. Immunol. Cell Biol. 77, 41-46.
74. Saklatvala J., Kaur P., and Guesdon F. (1991) Phosphorylation of the small heat-shock protein is regulated by interleukin 1, tumour necrosis factor, growth factors, bradykinin and ATP. Biochem. J. 277, 635-642.
75. Kaur P., Welch W. J., and Saklatvala J. (1989) Interleukin 1 and tumour necrosis factor increase phosphorylation of the small heat shock protein. Effects in fibroblasts, Hep G2 and U937 cells. FEBS Lett. 258, 269-273.
76. Nakano M., Knowlton A. A., Yokoyama T., Lesslauer W., and Mann D. L. (1996) Tumor necrosis factor-alpha-induced expression of heat shock protein 72 in adult feline cardiac myocytes. Am. J. Physiol. 270, H1231-1239.
77. Bajramovic J. J., Bsibsi M., Geutskens S. B., Hassankhan R., Verhulst K. C., Stege G. J., et al. (2000) Differential expression of stress proteins in human adult astrocytes in response to cytokines. J. Neuroimmunol. 106, 14-22.
78. Tezel G., Edward D. P., and Wax M. B. (1999) Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch. Ophthalmol. 117, 917-924.
79. Romano C., Barrett D. A., Li Z., Pestronk A., and Wax M. B. (1995) Anti-rhodopsin antibodies in seta from patients with normal-pressure glaucoma. Invest. Ophthalmol. Vis. Sci. 36, 1968-1975.
80. Wax M. B., Tezel G., Saito I., Gupta R. S., Harley J. B., Li Z., and Romano C. (1998) Anti-Ro/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am. J. Ophthalmol. 125, 145-157.
81. Tezel G., Seigel G. M., and Wax M. B. (1998) Autoantibodies to small heat shock proteins in glaucoma. Invest. Ophthalmol. Vis. Sci. 39, 2277-2287.
82. Maruyama I., Ohguro H., and Ikeda Y. (2000) Retinal ganglion cells recognized by serum autoantibody against gamma- enolase found in glaucoma patients. Invest. Ophthalmol. Vis. Sci. 41, 1657-1665.
83. Yang J., Tezel G., Patil R. V., Romano C., and Wax M. B. (2001) Serum autoantibody against glutathione S-transferase in patients with glaucoma. Invest. Ophthalmol. Vis. Sci. 42, 1273-1276.
84. Romano C., Li Z., Arendt A., Hargrave P. A., and Wax M. B. (1999) Epitope mapping of antirhodopsin antibodies from patients with normal pressure glaucoma. Invest. Ophthalmol. Vis. Sci. 40, 1275-1280.
85. Neufeld A. H. (1999) Microglia in the optic nerve head and the region of parapapillary chorioretinal atrophy in glaucoma. Arch. Ophthalmol. 117, 1050-1056.
86. Yang J., Yang P., Tezel G., Patil R. V., Hernandez M. R., and Wax M. B. (2001) Induction of HLA-DR expression in human lamina cribrosa astrocytes by cytokines and simulated ischemia. Invest. Ophthalmol. Vis. Sci. 42, 365-371.
87. Yang J., Patil R. V., Yu H., Gordon M., and Wax M. B. (2001) T cell subsets and sIL-2R/IL-2 levels in patients with glaucoma. Am. J. Ophthalmol. 131, 421-426.
88. Schwartz M. and Kipnis J. (2001) Protective autoimmunity: regulation and prospects for vaccination after brain and spinal cord injuries. Trends Mol. Med. 7, 252-258.
89. Yoles E., Hauben E., Palgi O., Agranov E., Gothilf A., Cohen A., et al. (2001) Protective autoimmunity is a physiological response to CNS trauma. J. Neurosci. 21, 3740-3748.
90. Guenal I., Sidoti-de Fraisse C., Gaumer S., and Mignotte B. (1997) Bcl-2 and Hsp27 act at different levels to suppress programmed cell death. Oncogene 15, 347-360.
91. Tezel G., Hernandez M. R., and Wax M. B. (2000) Immunostaining of heat shock proteins in the retina and optic nerve head of normal and glaucomatous eyes. Arch. Ophthalmol. 118, 511-518.
92. Park K. H., Cozier F., Ong O. C., and Caprioli J. (2001) Induction of heat shock protein 72 protects retinal ganglion cells in a rat glaucoma model. Invest. Ophthalmol. Vis. Sci. 42, 1522-1530.
93. Higashi T., Takechi H., Uemura Y., Kikuchi H., and Nagata K. (1994) Differential induction of mRNA species encoding several classes of stress proteins following focal cerebral ischemia in rats. Brain Res. 650, 239-248.
94. Hopkins D. A., Plumier J. C., and Currie R. W. (1998) Induction of the 27-kDa heat shock protein (Hsp27) in the rat medulla oblongata after vagus nerve injury. Exp. Neurol. 153, 173-183.
95. Costigan M., Mannion R. J., Kendall G., Lewis S. E., Campagna J. A., Coggeshall R. E., et al. (1998) Heat shock protein 27: developmental regulation and expression after peripheral nerve injury. J. Neurosci. 18, 5891-5900.
96. Mehlen P., Kretz-Remy C., Preville X., and Arrigo A. P. (1996) Human hsp27, Drosophila hsp27 and human alphaB-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J. 15, 2695-2706.
97. Mehlen P., Schulze-Osthoff K., and Arrigo A. P. (1996) Small stress proteins as novel regulators of apoptosis. Heat shock protein 27 blocks Fas/APO-1- and staurosporine-induced cell death. J. Biol. Chem. 271, 16510-16514.
98. Mehlen P., Hickey E., Weber L. A., and Arrigo A. P. (1997) Large unphosphorylated aggregates as the active form of hsp27 which controls intracellular reactive oxygen species and glutathione levels and generates a protection against TNFalpha in NIH-3T3-ras cells. Biochem. Biophys. Res. Commun. 241, 187-192.
99. Park Y. M., Han M. Y., Blackburn R. V., and Lee Y. J. (1998) Overexpression of HSP25 reduces the level of TNF alpha-induced oxidative DNA damage biomarker, 8-hydroxy-2′-deoxyguanosine, in L929 cells. J. Cell Physiol. 174, 27-34.
100. Baek S. H., Min J. N., Park E. M., Han M. Y., Lee Y. S., Lee Y. J., and Park Y. M. (2000) Role of small heat shock protein HSP25 in radioresistance and glutathione-redox cycle. J. Cell Physiol. 183, 100-107.
101. Caprioli J., Kitano S., and Morgan J. E. (1996) Hyperthermia and hypoxia increase tolerance of retinal ganglion cells to anoxia and excitotoxicity. Invest. Ophthalmol. Vis. Sci. 37, 2376-2381.
102. Young D. B. (1992) Heat-shock proteins: immunity and autoimmunity. Curr. Opin. Immunol. 4, 396-400.